Author

Michail V. Sitkovsky

Northeastern UniversityORCID 0000-0002-9819-9729Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

Stephen Matthew HatfieldiD· 2 shared Alexandra NukoviciD· 1 shared Ashley C Apro· 1 shared Brittany Noonan· 1 shared Bruce D. SpiessiD· 1 shared Camille Bahr· 1 shared Edwin Kerry JacksoniD· 1 shared Emilia Todorovic· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Stephen Matthew HatfieldORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oxygen-generating cryogel vaccines help overcome tumor antigen tolerance and induce durable anti-tumor immunity in prostate cancer

Alexandra Nukovic, Khushbu Bhatt, Thibault Colombani, Emilia Todorovic, Lucy M Williamson, Brittany Noonan, Enrique M Chang, Laura Losada Miguéns, Michail V. Sitkovsky, Sidi A. Bencherif, Stephen Matthew Hatfield

This study develops a cryogel vaccine platform that generates oxygen to overcome tumor antigen tolerance and induce durable anti-tumor immunity in prostate cancer.

Cell Biomaterials · Sep 1, 2026Peer-reviewedBioengineering

Oxygen carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia-induced suppression and improve cancer immunotherapy

Katarina Halpin-Veszeleiova, Michael P. Mallouh, Lucy M. Williamson, Ashley C Apro, Nuria Roxana Botticello-Romero, Camille Bahr, Maureen Shin, Kelly M. Ward, Laura Rosenberg, Vladimir B. Ritov, Michail V. Sitkovsky, Edwin Kerry Jackson, Bruce D. Spiess, Stephen Matthew Hatfield

This study shows oxygen-carrying nanoemulsions and respiratory hyperoxia reduce tumor hypoxia, enhance T cell and NK cell infiltration, and improve cancer immunotherapy outcomes.

JCI Insight · Mar 23, 2025Peer-reviewedImmunology